High-dose hydroxyurea plus G-CSF mobilize BCR-ABL-negative progenitor cells (CFC, LTC-IC) into the blood of newly diagnosed CML patients at any time of hematopoietic regeneration

Journal of Hematotherapy and Stem Cell Research

Volumn 11, Issue 2, 2002, Pages 293-300

  Petzer, Andreas L ^a   Gunsilius, Eberhard ^a   Hochenburger, Elmar ^a   Haun, Margot ^a   Ch Duba, Hans ^b   Grünewald, Kurt ^a   Hoflehner, Elisabeth ^a   Sill, Heinz ^c   Linkesch, Werner ^c   Gastl, Günther ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY HOSPITAL GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYUREA; INTERLEUKIN 6; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR;

ADULT; APHERESIS; ARTICLE; BLOOD; BLOOD TOXICITY; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOGENETICS; ERYTHEMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOTYPE; HUMAN; MALE; MUCOSA INFLAMMATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; AUTOTRANSPLANTATION; CLINICAL TRIAL; DRUG COMBINATION; GENETICS; HEMATOPOIESIS; METHODOLOGY; MIDDLE AGED; MYELOID LEUKEMIA; PATHOLOGY; PILOT STUDY; STANDARD; STEM CELL MOBILIZATION;

ADULT; BLOOD COMPONENT REMOVAL; DRUG THERAPY, COMBINATION; FEMALE; FUSION PROTEINS, BCR-ABL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; HYDROXYUREA; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; PILOT PROJECTS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0036223728     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581602753658475     Document Type: Article

References (27)

1. Autologous transplants for chronic myelogenous leukaemia: Results from eight transplant groups
2. Autologous stem cell transplantation in chronic myelogenous leukemia: A retrospective analysis of the European Group for Bone Marrow Transplantation
3. Autografting in chronic myeloid leukaemia
4. Autologous transplantation therapy for chronic myelogenous leukemia
5. Normal primitive haemopoietic progenitors are more frequent than their leukaemic counterpart in newly diagnosed patients with chronic myeloid leukaemia but rapidly decline with time
6. The biology of normal and neoplastic stem cells in CML
7. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia
8. Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia
9. Comparative analysis of autografting in chronic myelogenous leukemia: Effects of priming regimen and marrow or blood origin of stem cells
10. Collection of peripheral-blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive-dose chemotherapy
11. Treatment of chronic myeloid leukaemia in first chronic phase with idarubicin and cytarabine: Mobilization of Philadelphia-negative peripheral blood stem cells
12. Mobilization of Philadelphia-negative peripheral blood mononuclear cells in chronic myeloid leukaemia using hydroxyurea and G-CSF (filgrastim)
13. Quantitative competitive reverse transcriptase-polymerase chain reaction for BCR-ABL on Philadelphia-negative leukaphereses allows the selection of low-contaminated peripheral blood progenitor cells for autografting in chronic myelogenous leukemia
14. Prognostic discrimination in "good-risk" chronic granulocytic leukemia
15. Basic techniques for the preparation and analysis of chromosomes from bone marrow and leukaemic blood
16. Hypermetaphase- and interphase fluorescence in situ hybridization (FISH) for monitoring of remission status in Philadelphia chromosome positive chronic myeloid leukemia
17. Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer
18. Evaluation of optimal survival of primitive progenitor cells (LTC-IC) from PBPC apheresis products after overnight storage
19. Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor
20. Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia
21. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells
22. Monitoring of remission status by fluorescence in situ hybridisation in chronic myeloid leukaemia patients treated with interferon-alpha
23. Allogeneic hematopoietic stem cell transplantation: From the nuclear age into the twenty-first century
24. Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation
25. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
26. Mobilization and reinfusion of Philadelphia negative peripheral blood mononuclear cells in chronic myeloid leukaemia with hydroxyurea and G-CSF
27. Very primitive hematopoietic cells (LTC-IC) are present in Philadelphia negative cytaphereses during early recovery after chemotherapy for chronic myeloid leukemia (CML)